In This Section
Dr. Levy-Erez's research is focused on the discovery of immune urinary biomarkers among children developing acute kidney injury. She is studying both a unique population of immune-compromised children after hematopoietic stem cell transplantation (HSCT) as well as children who have an intact immune system who develop acute kidney injury after cardiac bypass surgery.
A clinician and researcher, Dr. Levy-Erez brings a unique vision to her research and is a leader in translational research in nephrology. She focuses on acute kidney injury as well as kidney disease among unique populations such as children undergoing HSCT. Seeing these patients with high morbidity and mortality has driven her to improve outcomes for these patients and has fueled her interest in biomarkers and mechanisms.
Dr. Levy-Erez's translational research focuses on discovery of biomarkers after acute kidney injury in immune-competent (cardiac bypass patients) as well as immune-suppressed patients (after hematopoietic cell transplant). Besides translational research she is involved in clinical research focused on improving outcomes of patients receiving dialysis as well as rarer diseases such as alport disease.
Education and Training
MD, Ben Gurion University, Goldman Medical School, 2008
Fellowship, Children's Hospital of Philadelphia (Pediatric Nephrology), 2018
Titles and Academic Titles
Clinical Instructor of Pediatrics
Israeli Clinical Pediatric Association, 2009
American Society of Pediatric Nephrology, 2015
Renal Physician Association, 2016
American Society of Nephrology, 2017
Lydia Eviatar Award for Research, Schneider Medical Center, 2013
Travel award to attend the FOCIS - Immunology Course, 2017
Young investigator Travel Award, Pediatric American Societies, 2017
Fellows Travel Award, American Society of Nephrology, 2017